What is the treatment for Carbosulfan poisoning?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Carbosulfan poisoning treatment involves immediate administration of atropine for severe symptoms, early endotracheal intubation, and benzodiazepines for seizures and agitation.

Treatment Overview

  • Atropine is recommended for severe poisoning, such as bronchospasm, bronchorrhea, seizures, or significant bradycardia, with doses often required to be higher than for typical bradycardia and administered until full atropinization is achieved 1.
  • Early endotracheal intubation is recommended for life-threatening organophosphate or carbamate poisoning, as observational data suggest better outcomes with this approach 1.
  • Benzodiazepines, such as diazepam or midazolam, are used to treat seizures and agitation in the setting of organophosphate or carbamate poisoning 1.

Additional Considerations

  • Pralidoxime may be considered for organophosphate poisoning, but its use in carbamate poisoning is not well established 1.
  • Dermal decontamination is recommended for external organophosphate or carbamate exposure 1.
  • Personal protective equipment should be used when caring for patients with organophosphate or carbamate exposure 1.

From the Research

Treatment for Carbosulfan Poisoning

The treatment for carbosulfan poisoning involves a combination of supportive measures and specific antidotal treatment.

  • The medical management of carbamate poisoning, including carbosulfan, consists of supportive measures and specific antidotal treatment, such as the anticholinergic compound atropine 2.
  • The administration of oximes, acetylcholinesterase reactivators, in carbamate poisoning is controversial, but recent data suggest that this concern may be unwarranted 2.
  • A combination of atropine and memantine remains the most effective antidotal treatment against acute carbofuran toxicity, which may also be applicable to carbosulfan poisoning 3.
  • For patients with carbosulfan poisoning, intubation and ventilation may be required, and the clinical presentation and cause of death do not differ markedly between carbamates 4.
  • Multiple dose-activated charcoal may be used as a treatment, but it can cause acute appendicitis as a side effect 5.

Antidotal Treatment

The antidotal treatment for carbosulfan poisoning includes:

  • Atropine, an anticholinergic compound, to counteract the effects of carbosulfan on the nervous system 2, 3.
  • Oximes, such as pralidoxime, trimedoxime, obidoxime, and HI-6, as acetylcholinesterase reactivators, although their use is controversial 2, 6.
  • Memantine, in combination with atropine, for the treatment of acute carbofuran toxicity, which may also be applicable to carbosulfan poisoning 3.

Supportive Measures

Supportive measures for carbosulfan poisoning include:

  • Gastric lavage to remove the toxin from the stomach 5.
  • Multiple dose-activated charcoal to prevent further absorption of the toxin 5.
  • Intubation and ventilation to support respiratory function 4.
  • Monitoring of vital signs and treatment of any related complications 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Carbofuran toxicity.

Journal of toxicology and environmental health, 1994

Research

Multiple dose-activated charcoal as a cause of acute appendicitis.

Journal of toxicology. Clinical toxicology, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.